Seeing Is Believing
Currently out of the existing stock ratings of Gena Wang, 199 are a BUY (67.92%), 66 are a HOLD (22.53%), 28 are a SELL (9.56%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 61.46% that have a potential upside of 24.66% achieved within 172 days.
Gena Wang’s has documented 577 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 09-May-2025.
Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$325
$73.85 (29.40%)
$300
14 days ago
(02-May-2025)
8/12 (66.67%)
$65.61 (25.29%)
324
Hold
$268
$16.85 (6.71%)
$284
1 months 5 days ago
(11-Apr-2025)
10/10 (100%)
$30.23 (12.71%)
39
Buy
$320
$68.85 (27.41%)
$320
1 months 7 days ago
(09-Apr-2025)
12/20 (60%)
$76.73 (31.54%)
215
Buy
$500
$248.85 (99.08%)
$500
1 months 14 days ago
(02-Apr-2025)
1/25 (4%)
$233.17 (87.39%)
664
Buy
$345
$93.85 (37.37%)
$295
1 months 15 days ago
(31-Mar-2025)
17/18 (94.44%)
$74.98 (27.77%)
247
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?